Multiple Myeloma is a type of cancer of the Bone Marrow in which myeloma cells multiply abnormally and start to replace the normal plasma cells. This adversely affects the body’s ability to produce antibodies, provide immunity and also weakens the bones. The tumour formed by these malignant plasma cells is called Plasmacytoma and the condition in which many such tumours are developed is known as Multiple Myeloma.
Multiple Myeloma can be diagnosed by regular Blood Tests which will show M proteins and some abnormal globulins that are produced by the Myeloma cells. It may also show an increased level of Calcium in the blood and very few Red Blood Cells (Anaemia). Bone Marrow Aspiration and Biopsy are essential to confirm Multiple Myeloma. Cells of the bone marrow are observed under the microscope to assess abnormalities and the type of Myeloma cells. MRI scan, CT scan and other imaging tests are helpful to see detailed pictures of the bones. Urine tests are also required in order to confirm the type of proteins produced and to assess its effect on the kidney.
In case of a bone marrow transplant, the patient is monitored by the doctor for signs of graft rejection. A medication for GVHD is given to prevent it from occurring. Antifungals, antivirals and antibiotics are also given in order to prevent all sorts of infections. Regular blood tests are conducted in order to check if blood counts are back to normal and to check the functioning of the donor’s stem cells in the recipient. The patient may require blood transfusions in case of too much blood loss or slow recovery.
MBBS, MD(General Medicine), DM(Clinical Haemotology) - Hematologist
MBBS, DNB(General Medicine), DM(Clinical Hematology) - Hematologist
MBBS, MD (General Medicine), MRCP, DRC(Pathology), MRCPath, FRCPath, CCST (Haematology) - Hematologist
MBBS - Hematologist